Beruflich Dokumente
Kultur Dokumente
AKI stage I
Creatinine criteria
Prerenal
ATN
UNa
< 20
> 40
FeNa
< 1%
> 4%
U/PCreat
> 40
< 20
FeUN
< 35%
>70%
Albuminuria
Dysmorphic Hematuria
Red cell casts
Glomerulonephritis
Atheroembolic disease
Thrombotic
microangiopathy
Minimal change
disease
Focal segmental
glomerulosclerosis
Tubular proteinuria
White cells
White cell casts
Eosinophiluria
Tubular epithelial
injury
-Ischemic
-Nephrotoxic
Interstitial
nephritis
Urinary tract
infection
Crystalluria
Drug toxicity
Urate crystals
-Urate nephropathy
Calcium oxalate
crystals
-ethylene glycol
Composed of
Tamm-Horsfall
mucoprotein.
Represent degenerating
cellular casts or aggregated
protein.
Nonspecific.
Waxy Casts:
Smooth appearance.
Blunt ends.
May have a crack.
Felt to be last stage of
degenerating cast
representative of chronic
disease.
Hematuria
Nonglomerular hematuria:
Urologic causes.
Bladder/Foley trauma.
Nephrolithiasis.
Urologic malignancy.
May be crenated based
upon age of urine, osmolality
NOT dysmorphic.
Medications
CYA, Tacrolimus
ACE inhibitors NSAIDS
Radiocontrast Amphotericin B
Aminoglycosides
Hepatorenal
Syndrome
Generalized
or Localized Reduction in
Renal Blood Flow
Sepsis
Ischemic
Acute Renal Failure
Vasculitis Atheroemboli
Thrombotic Microangiopathies
Transplant Rejection
Acute Glomerulopathies
RPGN most commonly seen with:
Lupus nephritis (DPGN, class IV)
Pauci-immune GN (ANCA associated)
Anti-GBM disease
less commonly: IgA, post-infectious
Nephrotic presentations of ARF
Collapsing FSGS (HIV nephropathy)
Minimal change disease with ATN
Thrombotic microangiopathies (HUS, TTP, malignant hypertension,
scleroderma kidney, pre-eclampsia)
Chronic or acute liver disease with advanced hepatic failure and portal
hypertension
Low GFR, as indicated by a serum creatinine >1.5 mg/dL or a creatinine
clearance < 40 mL/min
Absence of shock, ongoing bacterial infection, fluid loss, and current or
recurrent treatment with nephrotoxic drugs. Absence of gastrointestinal fluid
losses (repeated vomiting or intense diarrhea) or renal fluid losses (as
indicated by weight loss > 500 gm/d for several days in patients with ascites
without peripheral edema or > 100 gm/d in patients with peripheral edema)
No sustained improvement in renal function (decrease in serum creatinine to
1.5 mg/dL or less or increase in creatinine clearance to 40 ml/min or more)
after withdrawal of diuretics and expansion of plasma volume with 1.5 L of
isotonic saline
Proteinuria < 500 mg/d and ultrasonographic evidence of obstructive uropathy
or parenchymal renal disease.
Definition of
CKD-Mineral and Bone Disorder
A systemic disorder of mineral and bone
metabolism due to CKD manifested by either
one or a combination of the following:
Abnormalities of calcium, phosphorus, PTH, or
vitamin D metabolism
Abnormalities in bone turnover, mineralization,
volume, linear growth, or strength
Vascular or other soft tissue calcification
Moe S, et al. Kidney Int 69: 1945, 2006
ADPKD
ARPKD
VHL : AD,hemangioblastoma, RCC (40-70%)
TS: angiomyolipomas in CNS
MSK : AD, 3rd & 4th decade, stones, recurrent hematuria.
NPH =3 types:juvenille,infantile,adolescent. AR.
Cerebellar ataxia , hepatic fibrosis
MCK = AD. 3rd & 4th decade.